The glycyl-l-histidyl-l-lysine-Cu2+ tripeptide complex attenuates lung inflammation and fibrosis in silicosis by targeting peroxiredoxin 6
Redox Biology · 2024-09 · 75 · 103237
DOI: 10.1016/j.redox.2024.103237 ↗Kurz gefasst
Fachartikel in der Zeitschrift Redox Biology, 2024-09. Verfasst von Yiding Bian und 10 weiteren Autor:innen. Beteiligte Einrichtung: National Center for Respiratory Medicine; State Key Laboratory of Respiratory Health and Multimorbidity; National Clinical Research Center for Respir…. Hauptthemen laut MEDLINE: Silicosis, Copper, Oligopeptides, Peroxiredoxin VI. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Silicosis is the most common type of pneumoconiosis, having a high incidence in workers chronically exposed to crystalline silica (CS). No specific medication exists for this condition. GHK, a tripeptide naturally occurring in human blood and urine, has antioxidant effects. We aimed to investigate the therapeutic effect of GHK-Cu on silicosis and its potential underlying molecular mechanism. An experimental silicosis mouse model was established to observe the effects of GHK-Cu on lung inflammation and fibrosis. Moreover, the effects of GHK-Cu on the alveolar macrophages (AM) were examined using the RAW264.7 cell line. Its molecular target, peroxiredoxin 6 (PRDX6), has been identified, and GHK-Cu can bind to PRDX6, thus attenuating lung inflammation and fibrosis in silicosis mice without significant systemic toxicity. These effects were partly related to the inhibition of the CS-induced oxidative stress in AM induced by GHK-Cu. Thus, our results suggest that GHK-Cu acts as a potential drug by attenuating alveolar macrophage oxidative stress. This, in turn, attenuates the progression of pulmonary inflammation and fibrosis, which provides a reference for the treatment of silicosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- National Center for Respiratory Medicine; State Key Laboratory of Respiratory Health and Multimorbidity; National Clinical Research Center for Respiratory Diseases; Institute of Respiratory Medicine, Chinese Academy of…
- Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China.
- Department of Pulmonary and Critical Care Medicine, Disease, Fuwai Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, China. Electronic address: zhouxmcmu@163.com.
Zitieren
APA
Bian, Y., Deng, M., Liu, J., Li, J., Zhang, Q., Wang, Z., Liao, L., Miao, J., Li, R., Zhou, X., & Hou, G. (2024). The glycyl-l-histidyl-l-lysine-Cu2+ tripeptide complex attenuates lung inflammation and fibrosis in silicosis by targeting peroxiredoxin 6. Redox Biology, 75, 103237. https://doi.org/10.1016/j.redox.2024.103237
Vancouver
Bian Y, Deng M, Liu J, Li J, Zhang Q, Wang Z, et al. The glycyl-l-histidyl-l-lysine-Cu2+ tripeptide complex attenuates lung inflammation and fibrosis in silicosis by targeting peroxiredoxin 6. Redox Biology. 2024;75:103237. doi:10.1016/j.redox.2024.103237
BibTeX
@article{Bian2024,
author = {Bian, Yiding and Deng, Mingming and Liu, Jia and Li, Jiaye and Zhang, Qin and Wang, Zilin and Liao, Liwei and Miao, Jinrui and Li, Ruixia and Zhou, Xiaoming and Hou, Gang},
title = {The glycyl-l-histidyl-l-lysine-Cu2+ tripeptide complex attenuates lung inflammation and fibrosis in silicosis by targeting peroxiredoxin 6},
journal = {Redox Biology},
year = {2024},
volume = {75},
pages = {103237},
doi = {10.1016/j.redox.2024.103237}
}
EUVIMED